课题基金 / 基金详情

The relationship between cell proliferation and RANKL-induced osteoclastogenesis

The relationship between cell proliferation and RANKL-induced osteoclastogenesis
细胞增殖与RANKL诱导的破骨细胞生成的关系
批准号:
18390495
负责人:
TAKAHASHI Naoyuki
金额:
$11.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TAKAHASHI Naoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1) In vitro analysis of the cell cycle in osteoclast progenitors : We have shown that cell cycle progression and withdrawal after the progression in osteoclast precursors are the two sequential events essential for RANKL-induced osteoclastogenesis.(2) The isolation and the analysis of QOPs: Cell cycle-arrested quiescent osteoclast precursors (QOPs) were identified as the committed osteoclast precursors in vitro. In vivo experiments showed that mononuclear cells expressing c-Fms and RANK but not Ki67 were detected along bone surfaces in the vicinity of osteoblasts in RANKL-deficient mice. They were identified as QOPs.(3) BMP transplantation experiments using RANKL(-/-) mice and OPG(-/-) mice : We examined the requirements for osteoclastogenesis using OPG(-/-) mice, RANKL(-/-) mice and a system involving BMP-induced ectopic bone formation. We have shown that osteoblasts also play important roles in osteoclastogenesis through offering the critical microenvironment for the action of RANKL.(4) Establishment of the Cre-lox P system for osteoclast specific deletion of target genes : We have succeeded to establish RANK Cre mice. We are now analyzing the Cre recombinase expression in osteoclastss.(5) Transgenic mice of cell cycle regulatory genes : We are advancing experiments on osteoclast niche, in stead of the production of the cycle regulatory gene transgenic mice.(6) Clinical application of anti-cancer drugs in bone diseases : We have shown that that taxanes have beneficial effects on the treatment of bone metastatic cancers. Administration of an anti-cancer drug, 5-fluorouracil, to mice induced myelosuppression, but QOPs survived and differentiated into osteoclasts in response to an active vitamin D_3 analog given to those mice. We have shown that QOPs pre-exist at the site of osteoclastogenesis and that osteoblasts play roles in the maintenance of QuOPs in the undifferentiated state. We found that c-Fos(-/-) mice have not osteoclast niche.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
破骨細胞の形成部位を決める破骨細胞ニッチ
破骨细胞生态位决定破骨细胞形成的部位
DOI: --
发表时间: 2007
期刊: 医学の歩み 221
影响因子: --
作者: [Takahashi N, et. al., Nakamichi Y, Sato M, Takahashi N, Udagawa N, Takahashi N, 高橋直之]
通讯作者: 高橋直之
Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes
降钙素对CD14阳性单核细胞形成的人破骨细胞样细胞功能的影响
DOI: --
发表时间: 2006
期刊: Cell Mol Biol 52
影响因子: --
作者: [Yamamoto Y, et. al.]
通讯作者: et. al.
Docetaxel inhibits bone resorption through suppression of osteoclast for mation and function in different manners
多西他赛通过不同方式抑制破骨细胞的形成和功能来抑制骨吸收
DOI: --
发表时间: 2008
期刊: J Bone Miner Metab 27(In press)
影响因子: --
作者: [Takahashi M, et. al.]
通讯作者: et. al.
Roles of Wnt in bone formation and resorption
Wnt 在骨形成和吸收中的作用
DOI: --
发表时间: 2008
期刊: Japanese Dental Science Review (In press)
影响因子: --
作者: [Kobayashi Y, et. al.]
通讯作者: et. al.
32
    Do carbon nanotubes control bone remodeling?
    • 批准号:
      24659833
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    Role of Wnt-Ror2 signals in ruffled border formation in osteoclasts
    • 批准号:
      22659339
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.04万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    Analysis of osteoclast niche regulated by Wnt signals.
    • 批准号:
      22390351
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    Study on the molecular mechanism of alveolus bone resorption induced periodontal diseases
    • 批准号:
      16390535
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    国内基金
    海外基金
    基于RANKL/RANK/OPG通路观察补肾活血方干预半月板白-白区撕裂后软骨下骨的研究
    基于“阴消阳长”理论从RANKL/RANK通路探讨阳和汤调控骨转移乳腺癌免疫微环境增敏免疫的机制研究
    • 批准号:
      2026JJ50610
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      毛丹
    • 依托单位:
    单核巨噬细胞通过RANK/RANKL/OPG 信号通路调控小鼠P3趾尖骨关节再生的机制研究
    • 批准号:
      JCZRYB202500176
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    RANKL-NFATc1-E-NPP4通路促进破骨细胞嘌呤代谢加速绝经后骨质疏松骨量流失的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      禹宝庆
    • 依托单位: